Relay Therapeutics (RLAY) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for Relay Therapeutics (RLAY) over the last 5 years, with Q4 2024 value amounting to $28.9 million.
- Relay Therapeutics' Accumulated Depreciation & Amortization rose 2260.2% to $28.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $28.9 million, marking a year-over-year increase of 2260.2%. This contributed to the annual value of $28.9 million for FY2024, which is 2260.2% up from last year.
- Latest data reveals that Relay Therapeutics reported Accumulated Depreciation & Amortization of $28.9 million as of Q4 2024, which was up 2260.2% from $23.6 million recorded in Q4 2023.
- In the past 5 years, Relay Therapeutics' Accumulated Depreciation & Amortization registered a high of $28.9 million during Q4 2024, and its lowest value of $10.5 million during Q4 2020.
- Over the past 5 years, Relay Therapeutics' median Accumulated Depreciation & Amortization value was $18.4 million (recorded in 2022), while the average stood at $19.2 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 3643.87% in 2021, then soared by 2260.2% in 2024.
- Quarter analysis of 5 years shows Relay Therapeutics' Accumulated Depreciation & Amortization stood at $10.5 million in 2020, then skyrocketed by 36.44% to $14.4 million in 2021, then rose by 27.99% to $18.4 million in 2022, then rose by 28.24% to $23.6 million in 2023, then rose by 22.6% to $28.9 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $28.9 million for Q4 2024, versus $23.6 million for Q4 2023 and $18.4 million for Q4 2022.